Should labs be drawn before or after dialysis in a skilled nursing facility patient with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Timing for Dialysis Patients in Skilled Nursing Facilities

Labs should be drawn both before AND after dialysis, with predialysis samples obtained immediately before dialysis initiation and postdialysis samples collected using the slow flow/stop pump technique immediately after dialysis completion. 1

Predialysis Laboratory Collection

Draw predialysis labs immediately before dialysis begins to accurately reflect the patient's baseline metabolic status and guide treatment decisions. 1, 2

Critical Predialysis Sampling Requirements:

  • Obtain the blood specimen before connecting arterial blood tubing or flushing the needle to prevent dilution with saline or heparin, which would artificially lower BUN values and compromise dialysis adequacy calculations. 1

  • For arteriovenous fistulas/grafts: Draw from the arterial needle prior to any line connection, ensuring no saline or heparin is present in the needle or tubing. 1

  • For venous catheters: Withdraw and discard 10 mL of blood (3-5 mL in pediatrics) after removing heparin/saline to ensure an undiluted sample. 1

  • Never draw predialysis samples after dialysis has started, as this will reflect dialyzed blood with artificially reduced solute concentrations, leading to falsely elevated dialysis adequacy measurements (Kt/V, URR) and incorrect volume calculations. 1

Postdialysis Laboratory Collection

Draw postdialysis labs immediately after dialysis ends using the slow flow/stop pump technique to accurately measure dialysis adequacy while minimizing urea rebound effects. 1, 2

Slow Flow/Stop Pump Technique (Preferred Method):

  1. At dialysis completion, turn off dialysate flow and reduce ultrafiltration rate to 50 mL/h or minimum setting. 1

  2. Decrease blood flow to 50-100 mL/min for 15 seconds to clear the arterial line of any recirculated blood. 1

  3. Draw the sample from the arterial sampling port closest to the patient while blood pump runs at 50-100 mL/min (slow flow technique) OR immediately after stopping the pump (stop pump technique). 1

  4. This timing is critical: Sampling must occur before significant urea rebound (which begins 2-3 minutes post-dialysis) but after access recirculation has resolved. 1

Why This Timing Matters:

  • Drawing postdialysis samples too early (before dialysis ends) increases the postdialysis BUN concentration, underestimating dialysis adequacy. 1

  • Drawing samples too late (>5 minutes after dialysis) allows urea rebound from tissue compartments, significantly elevating BUN and again underestimating dialysis adequacy. 1

  • The slow flow/stop pump technique provides minimal technical variability between sessions, making longitudinal comparisons of dialysis adequacy more accurate. 1

Monthly Monitoring Requirements for SNF Patients

Measure dialysis adequacy (Kt/V or URR) monthly using properly collected pre- and postdialysis BUN samples from the same dialysis session. 1, 2, 3

Additional Monthly Labs (Predialysis):

  • Hemoglobin (more stable and accurate than hematocrit). 3
  • Serum ferritin and transferrin saturation to guide iron therapy. 3
  • Electrolytes: sodium, potassium, calcium, phosphorus, magnesium, bicarbonate. 3

Quarterly Labs:

  • Serum albumin every 3 months as a nutritional marker and mortality predictor. 3

Common Pitfalls to Avoid

Dilution errors are the most common cause of inaccurate dialysis adequacy measurements. 1

  • Never flush lines with saline before drawing predialysis samples - this artificially lowers BUN, resulting in falsely elevated Kt/V/URR and incorrect treatment prescriptions. 1

  • Avoid drawing pre- and postdialysis samples from different dialysis sessions - this provides meaningless information about delivered dialysis dose due to interassay variability. 1

  • Do not use the blood reinfusion technique for postdialysis sampling - this less reproducible method allows excessive urea rebound (taking 5+ minutes), resulting in partially equilibrated samples that don't accurately reflect single-pool kinetic models. 1

  • Ensure both samples are analyzed by the same laboratory at the same time to minimize interassay variability, which accounts for most variation in dialysis adequacy measurements (4.0% coefficient of variation for Kt/V). 1

Clinical Context for SNF Patients

SNF dialysis patients have particularly high mortality risk (39.2% at 6 months), making accurate dialysis adequacy monitoring essential for optimizing outcomes. 4

  • These patients often have multiple nondisease-specific problems (cognitive impairment, functional dependence, polypharmacy) that increase mortality risk independent of dialysis adequacy. 4

  • Proper lab timing ensures accurate Kt/V measurement, allowing clinicians to distinguish between inadequate dialysis delivery versus other causes of poor outcomes in this vulnerable population. 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Comprehensive Assessment of Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Investigations and Infection Surveillance in Dialysis Units

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Do transfusion protocols change for patients with impaired renal function on dialysis?
What are the guidelines for initiating and managing hemodialysis in patients with impaired renal function?
What are the recommendations for ensuring hemodialysis adequacy in patients with impaired renal function?
What is the recommended treatment protocol for patients requiring hemodialysis (HD) due to impaired renal function?
Can Ramelteon (ramelteon) be used in patients with impaired renal function undergoing dialysis?
What are the considerations for an adult cancer patient with gastrointestinal symptoms when taking pantoprazole (Proton Pump Inhibitor) and pembrolizumab (Programmed Death receptor-1 (PD-1) inhibitor)?
What is an alternative medication for a patient with primary hyperparathyroidism currently taking cinacalcet (calcimimetic agent) who is facing a medication backorder?
What do patients with type 2 diabetes or obesity need to know about semaglutide (glucagon-like peptide-1 receptor agonist) therapy?
What are the management options and prognosis for an adult patient with a history of melanoma, now presenting with metastasis to the brain, a clot in the superior sagittal vein, and a larger brain bleed in the left temporal lobe around the melanoma metastasis?
What are the guidelines for using proton pump inhibitors (PPI) in adult cancer patients with a history of gastrointestinal issues, such as gastroesophageal reflux disease (GERD) or peptic ulcer disease, who are receiving pembrolizumab, a monoclonal antibody?
Would a consultation for laser/light therapy for a patient with chronic rosacea, who has failed azelaic acid and metronidazole gel treatments, be approved as a cosmetic and out-of-pocket procedure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.